JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of QVAR® (beclomethasone dipropionate ...
Study reveals that patients treated with QVAR had a similar or better chance of achieving asthma control at lower prescribed doses than with fluticasone HORSHAM, Pa., Sept. 8 /PRNewswire/ -- Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results